Millennium Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
595,673
+201,242
| +51% | +$545K | ﹤0.01% | 2779 |
|
|
2025
Q1 | $887K | Sell |
394,431
-3,571,001
| -90% | -$8.03M | ﹤0.01% | 3040 |
|
|
2024
Q4 | $13.9M | Sell |
3,965,432
-1,429,259
| -26% | -$5M | 0.01% | 1341 |
|
|
2024
Q3 | $22.2M | Buy |
5,394,691
+2,192,986
| +68% | +$9.01M | 0.01% | 1041 |
|
|
2024
Q2 | $11.5M | Buy |
3,201,705
+1,022,570
| +47% | +$3.68M | 0.01% | 1386 |
|
|
2024
Q1 | $7.19M | Buy |
2,179,135
+768,818
| +55% | +$2.54M | ﹤0.01% | 1724 |
|
|
2023
Q4 | $3.26M | Buy |
1,410,317
+166,732
| +13% | +$385K | ﹤0.01% | 2172 |
|
|
2023
Q3 | $1.6M | Buy |
1,243,585
+288,514
| +30% | +$372K | ﹤0.01% | 2625 |
|
|
2023
Q2 | $1.26M | Sell |
955,071
-1,550,559
| -62% | -$2.05M | ﹤0.01% | 2783 |
|
|
2023
Q1 | $1.77M | Buy |
2,505,630
+1,194,281
| +91% | +$844K | ﹤0.01% | 2626 |
|
|
2022
Q4 | $984K | Buy |
1,311,349
+57,738
| +5% | +$43.3K | ﹤0.01% | 3183 |
|
|
2022
Q3 | $1.08M | Buy |
1,253,611
+551,715
| +79% | +$475K | ﹤0.01% | 3284 |
|
|
2022
Q2 | $786K | Sell |
701,896
-216,162
| -24% | -$242K | ﹤0.01% | 3598 |
|
|
2022
Q1 | $1.03M | Sell |
918,058
-32,976
| -3% | -$36.9K | ﹤0.01% | 3555 |
|
|
2021
Q4 | $1.52M | Sell |
951,034
-483,510
| -34% | -$774K | ﹤0.01% | 3164 |
|
|
2021
Q3 | $3.47M | Sell |
1,434,544
-229,406
| -14% | -$555K | ﹤0.01% | 2540 |
|
|
2021
Q2 | $5.28M | Sell |
1,663,950
-925,417
| -36% | -$2.93M | ﹤0.01% | 2082 |
|
|
2021
Q1 | $8.73M | Buy |
2,589,367
+2,428,187
| +1,507% | +$8.18M | 0.01% | 1515 |
|
|
2020
Q4 | $577K | Buy |
+161,180
| New | +$577K | ﹤0.01% | 3158 |
|